Partnership · KRECE — Precision Longevity

The Spanish-Speaking
Longevity Market

Your reach in Spanish is zero. Ours is 73 articles, 6 verticals, and a distribution network ready to move product.

KRECE is the #1 evidence-based longevity editorial in Spanish. We evaluate peptides, supplements and cosmeceuticals with pharmaceutical-grade rigor, publish the evidence, and distribute finished products from selected international brands across LATAM, MERCOSUR and the EU. We are both your editorial presence and your regulatory & distribution infrastructure in markets where the regulatory barrier is the real competitive moat.

73
Articles evaluated with evidence pyramid (N0-N5)
6
Verticals: Brain, Beauty, Repair, Longevity, Performance, Metabolic
8+
Target markets across LATAM & Europe — Phase 1 active
B2B
Medical channel + direct-to-consumer in Paraguay
01 Why KRECE · What we bring to your brand

You make the product. We make it exist in the Spanish-speaking world — editorially, commercially, and regulatorily.

01 · Editorial
The #1 longevity editorial in Spanish

73 articles published with our proprietary evidence pyramid (N0-N5). Doctors and informed patients across LATAM and Spain find KRECE through organic search — no advertising spend. When we evaluate your product, it reaches prescribers and consumers who trust our position because we take one publicly.

73
Articles with evidence level
02 · Distribution
Commercial infrastructure in Paraguay

A dedicated Commercial Director in Asunción leads a network of 2 commissioned sales representatives and approximately 50 qualified B2B and B2B2C contacts — clinics, pharmacies, nutritionists, aesthetic centers and health professionals. Product moves through human channels, not just digital ones.

50+
Qualified B2B contacts in Paraguay
03 · Regulatory
Import & compliance infrastructure

KRECE LLC (Wyoming, USA) as international holding. Local entity in Paraguay scheduled for incorporation in May 2026, with established contact at DINAVISA (national regulator) and import/customs infrastructure in place. EU market access via our Spanish entity. We navigate the regulatory barriers that keep competitors out.

3
Legal entities: USA · Paraguay · Spain
“The biology of aging knows no borders. Longevity science shouldn’t be exclusive to those lucky enough to live in the right country.”
KRECE · Founding principle · 2026
02 What we look for · Product categories
Category 01
Clinical-Grade Supplements

Brands with proprietary formulations and documented active doses. No cosmetic dosing. No proprietary blends that hide underdosing. We evaluate with the same rigor we apply to peptides — if the data doesn’t hold, it doesn’t enter the catalog.

NAD+/NMN · Longevity stacks · Marine collagen · Premium functionals · Geroprotector formulations
Category 02
Cosmeceuticals with Data

Topical active ingredients with documented mechanisms. Retinoids, peptide actives (GHK-Cu), niacinamide, stabilized vitamin C, ceramides. We serve the pharmacy and aesthetic clinic channel — products need to pass clinical scrutiny, not just sensory appeal.

Pharmacy channel · Aesthetic clinics · Dermatology-grade actives · Documented penetration data
Category 03
Emerging Brands Ready to Scale

D2C brands with a proven product in their home market looking for international expansion. KRECE offers the route: Paraguay as the launchpad, MERCOSUR as the first expansion, LATAM and EU as the end game. We handle regulation, import and distribution — you focus on product.

Proven D2C brands · Looking for LATAM entry · Open to exclusive distribution · Product-market fit validated
03 Markets · 8+ countries · 3-year roadmap
Phase 1 · Now
Year 1 · 2026
Paraguay (HQ, first market)
Uruguay
Argentina
Chile
Colombia
MERCOSUR cosmetic framework. B2B medical channel as priority. B2C test in Paraguay.
Phase 2
Year 2 · 2027
Spain (EU accreditation)
Mexico
Peru & Ecuador (via CAN)
EU-MERCOSUR trade agreement active. Progressive tariff reduction. Mexico: evaluation vs. US-based suppliers.
Phase 3
Year 3 · 2028
Brazil (local partner, ANVISA)
US Hispanic market
Panama (logistics hub)
Brazil requires local partner. The US Hispanic market is the largest Spanish-language longevity audience.
EU ↔ MCS
Structural advantage · 2026
EU-MERCOSUR Free Trade Agreement

Progressive tariff reduction on pharmaceutical and cosmeceutical ingredients (currently 14-18%) between the European supply chain and LATAM markets. KRECE operates with registered entities on both sides: Spain (EU) and Paraguay (MERCOSUR). Partners benefit from improved economics over a 10-year horizon, with the largest reductions in the first three years.

Paraguay
DINAVISA · MERCOSUR cosmetics

Operational HQ and first market. Agile regulatory environment, active sales network, untapped functional medicine channel. 90-day B2C test as a market laboratory.

B2B clinics + B2C premium
Argentina
ANMAT · Compounding pharmacies

Sophisticated medical ecosystem. Developed network of compounding pharmacies. Dollar-denominated consumer segment in Buenos Aires with high purchasing power.

B2B anti-aging + B2C
Colombia
INVIMA · CAN Decision 516

CAN cosmetic registration simultaneously covers Peru, Ecuador and Bolivia. Medellín: Latin America’s medical tourism capital.

CAN hub + medical tourism
Chile
ISP · DS 239/2002

Highest per capita income in Spanish-speaking LATAM. Active anti-aging clinic ecosystem in Santiago. Premium segment justifies independent ISP registration.

B2C premium + B2B
Spain
AEMPS · EU Reg. 1223/2009

EU accreditation market. B2B via compounding pharmacy. EU registration opens access to all 27 European countries. EU-MERCOSUR agreement reduces transatlantic costs.

B2B compounding pharmacy
Uruguay
MSP · MERCOSUR

Most economically stable market in LATAM. No currency controls. Functions as a premium validation market and gateway to the Argentine diaspora.

Premium validation
04 How we work · Partnership model
01
Evaluation

We assess product-market fit across our three verticals. We review formulations, clinical documentation, regulatory status and commercial terms. If the product meets KRECE standards, it enters the pipeline.

02
Regulatory

We handle regulatory pathway mapping, DINAVISA registration in Paraguay, MERCOSUR cosmetic framework compliance, and import/customs documentation. You provide product specs — we handle the bureaucracy.

03
Launch

Product enters our distribution channels: B2B medical network, sales representatives, B2C via our Shopify store and KREC.IA (WhatsApp-based purchase advisor). Editorial coverage on krece.io drives organic awareness.

04
Scale

Once validated in Paraguay, we extend to MERCOSUR, then broader LATAM and EU. Same infrastructure, same regulatory know-how, new markets. KRECE grows with your brand.

“We don’t just distribute. We evaluate, we document, and we take a public position on every product we carry. That’s why doctors trust us.”
KRECE · Distribution philosophy
05 Contact · Let’s talk
Manufacturers · Brands · International Partnerships
Ready to enter the Spanish-speaking longevity market?

We are looking for brands with finished products, clinical documentation, and the ambition to scale internationally. Tell us about your product, your current markets, and what you’re looking for in LATAM and Europe. We respond within 48 hours.

KRECE LLC · Wyoming, USA · Asunción, Paraguay · Valladolid, Spain   |   krece.io   |   Evidence catalog
Índice editorial · 262 piezas en 12 categorías
Ver archivo completo →